DENTSPLY SIRONA Q3 EPS Forecast Reduced by Leerink Partnrs

Key Points

• Investment analysts at Leerink Partners have reduced their Q3 2025 earnings estimate for DENTSPLY SIRONA from $0.45 to $0.43 per share.
• The consensus estimate for DENTSPLY SIRONA's full-year earnings is currently projected at $1.84 per share.
• As of now, DENTSPLY SIRONA has an average target price of $18.00, with various analysts issuing ratings from "Buy" to "Sell."

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Investment analysts at Leerink Partnrs decreased their Q3 2025 earnings estimates for DENTSPLY SIRONA in a research note issued to investors on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will earn $0.43 per share for the quarter, down from their previous forecast of $0.45. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q4 2025 earnings at $0.46 EPS, FY2025 earnings at $1.83 EPS and FY2026 earnings at $1.97 EPS.

A number of other equities analysts have also recently weighed in on the company. UBS Group cut their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a report on Friday, August 8th. Wells Fargo & Company reduced their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, August 8th. Weiss Ratings reiterated a "sell (d-)" rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Finally, Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating for the company in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $18.00.

DENTSPLY SIRONA Stock Up 2.1%

DENTSPLY SIRONA stock opened at $12.47 on Wednesday. The firm has a market capitalization of $2.49 billion, a price-to-earnings ratio of -2.63, a price-to-earnings-growth ratio of 0.76 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA has a fifty-two week low of $11.69 and a fifty-two week high of $24.93. The stock's fifty day moving average is $13.42 and its two-hundred day moving average is $14.56.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company's revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the company earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. DENTSPLY SIRONA's payout ratio is presently -13.50%.

Institutional Trading of DENTSPLY SIRONA

Hedge funds have recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $25,000. Brooklyn Investment Group acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $26,000. Trust Co. of Toledo NA OH purchased a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at approximately $27,000. Finally, Parkside Financial Bank & Trust raised its holdings in DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,477 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.